Olema Pharmaceuticals, Inc. (OLMA)
15.13
-0.06
(-0.39%)
USD |
NASDAQ |
May 07, 16:00
15.13
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals SG&A Expense (TTM) : 21.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EyePoint, Inc. | 37.79M |
| CytomX Therapeutics, Inc. | 29.84M |
| Protagonist Therapeutics, Inc. | 33.12M |
| Disc Medicine, Inc. | 53.20M |
| Nuvalent, Inc. | 107.34M |